Hoechst Pakistan Limited
PPSX:HPL3,950.00
PKR
+7.71
(+0.20%)
Hoechst Pakistan Limited
PSX:HPL
(Pakistan Stock Exchange)
Recent
price
3,950.00
P/E
ratio
- -
div
yld
- -
ROIC.AI
Capital Structure
FRC
•
in mil. unless spec.Working Capital
FRC
•
in mil. unless spec.Growth Rates
FRC
•
in mil. unless spec.Quarterly Revenue
FRC
•
in mil. unless spec.Quarterly Earnings Per Share
FRC
•
in mil. unless spec.Quarterly Dividends Per Share
FRC
•
in mil. unless spec.- Similar Companies
- Business
- Hoechst Pakistan Limited is a Pakistan-based pharmaceutical and healthcare company engaged in the manufacturing, marketing, distribution, and sale of prescription pharmaceuticals, consumer healthcare products, vaccines, and nutraceutical formulations. The company operates across multiple therapeutic and business segments, providing products that include anti-infectives and antibiotics, such as Flagyl, Claforan, and Tarivid; diabetes care and oral anti-diabetic treatments, such as Amaryl; gastrointestinal, antiemetic, and antispasmodic medications, including No-Spa and Enterogermina; allergy and respiratory management therapies, including Avil and Telfast; cardiovascular and hypertension therapies; central nervous system and neurology treatments; oncology medications; emergency care therapeutics; and specialized therapies for rare diseases, including lysosomal storage disorders. Its manufacturing infrastructure, located in the Korangi Industrial Area in Karachi, produces oral solid dosage forms, liquid syrups and suspensions, and sterile injectable formulations for hospitals, retail pharmacies, clinics, and government healthcare institutions throughout Pakistan. In recent corporate developments, an investor consortium comprising Packages Limited, IGI Investments (Private) Limited, and affiliates of the Arshad Ali Gohar Group acquired the 52.87% controlling interest previously held by Sanofi Foreign Participations B.V. in April 2023. Following this ownership restructuring, the entity transitioned its name from Sanofi-Aventis Pakistan Limited back to Hoechst Pakistan Limited in September 2023 while maintaining licensing and production continuity for core pharmaceutical brands. In 2024, the company further diversified its operations by establishing a wholly owned subsidiary, H-Pack Wellness (Private) Limited, dedicated to the manufacturing and marketing of wellness, nutraceutical, and dietary supplement products. Founded in 1967 and listed on the Pakistan Stock Exchange under the ticker HPL, Hoechst Pakistan Limited is headquartered in Karachi, Pakistan.